Department of Cardiovascular Surgery, Renmin Hospital of Wuhan University Hubei Cardiovascular Medicine Clinical Research Center Hubei Key Laboratory of Cardiology, 430060, Wuhan, Hubei, China.
Department of Critical Care Medicine, Jin Yin-tan Hospital, Wuhan, Hubei, China.
Genes Immun. 2020 May;21(3):193-202. doi: 10.1038/s41435-020-0099-3. Epub 2020 May 27.
Maturation of dendritic cells (DCs) initiates adaptive immune responses and thereby provokes allograft rejection. Here, this study aimed to explore the effect of Methyltransferase-like protein 3 (METTL3) silencing on DC function and the role of METTL3-silencing donor DCs in the immune response after mouse heart transplantation. Bone marrow-derived DCs from donor BALB/c mice were infected with lentiviruses expressing METTL3-specific short hairpin RNA (LV-METTL3 shRNA) to silence METTL3. Then METTL3-silencing DCs were treated with lipopolysaccharide (LPS) for another 48 h to induce DC maturation. Recipient C57BL/6 mice were injected with phosphate-buffered saline (PBS), immature DCs, and METTL3 shRNA-DCs prior to the cardiac transplantation involving the transfer of hearts from donor BALB/c mice to recipient C57BL/6 mice. In vitro we demonstrated that METTL3-silencing DCs had lower expression of MHCII, costimulatory molecules (CD80, CD86), and DC-related cytokines (IFN-γ, IL-12) as well as lower ability to activate T-cell proliferation, which were consistent with the characteristics of tolerogenic DCs. In vivo we found that METTL3-silencing donor DCs induced immune tolerance after mouse heart transplantation and prolonged the allograft survival, which might be associated with Th1/Th2 immune deviation. In summary, METTL3-silencing DCs exhibit immature properties and prolong allograft survival.
树突状细胞(DCs)的成熟会引发适应性免疫反应,从而引发移植物排斥反应。本研究旨在探索甲基转移酶样蛋白 3(METTL3)沉默对 DC 功能的影响,以及 METTL3 沉默供体 DC 在小鼠心脏移植后免疫反应中的作用。用表达 METTL3 特异性短发夹 RNA(LV-METTL3 shRNA)的慢病毒感染供体 BALB/c 小鼠的骨髓来源 DC,以沉默 METTL3。然后,用脂多糖(LPS)处理沉默 METTL3 的 DC 48 小时以诱导 DC 成熟。在心脏移植前,将 C57BL/6 小鼠用磷酸盐缓冲液(PBS)、未成熟 DC 和 METTL3 shRNA-DC 注射。心脏供体来自 BALB/c 小鼠,受体为 C57BL/6 小鼠。体外实验表明,沉默 METTL3 的 DCs 表达较低水平的 MHCII、共刺激分子(CD80、CD86)和 DC 相关细胞因子(IFN-γ、IL-12),且激活 T 细胞增殖的能力降低,这些表现与耐受型 DC 相似。体内实验发现,沉默 METTL3 的供体 DC 在小鼠心脏移植后诱导免疫耐受,延长移植物存活,这可能与 Th1/Th2 免疫偏离有关。总之,沉默 METTL3 的 DC 具有不成熟的特性,并延长移植物存活。